Tourette Syndrome

160 registered clinical trials studyying Tourette Syndrome — 24 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Characterising Sleep Disorders in Children With Tourette Syndrome NCT07450079	Steffi Baker	—
Recruiting	Where Wild Things Grow: Nature- and Activity-based Group Interventions for Neurodivergent Children and Youth NCT07203469	Sorlandet Hospital HF	N/A
Not Yet Recruiting	SCI-110 in the Treatment of Tourette Syndrome NCT05126888	Neurothera Labs Inc.	Phase 2
Recruiting	Cognitive-psychophysiological Treatment for Tics in Young People With Tourette's Syndrome With or Without Biof NCT06873841	Université du Québec a Montréal	N/A
Recruiting	Trajectories of Change in Tourette Syndrome NCT06679790	University of Minnesota	N/A
Recruiting	CBIT+TMS R33 Phase NCT06678737	University of Minnesota	Phase 2
Recruiting	Multimodal Electrophysiological Study of Cortico-subcortical Biomarkers of Tics in Tourette Syndrome NCT06909656	University Hospital, Bordeaux	N/A
Recruiting	Effect of RNS in Treatment-refractory Tourette's Syndrome NCT06785532	Xuanwu Hospital, Beijing	N/A
Recruiting	Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder NCT06576726	Vanderbilt University Medical Center	—
Recruiting	Multitarget Stereotactic Electrophysiological Recording and Stimulation for Tourette Syndrome NCT06889480	Beijing Tiantan Hospital	N/A
Recruiting	Effectiveness of Symptom Management Application on Parental Care Ability of Children With Tourette Syndrome NCT06613126	National Taipei University of Nursing and Health Sciences	N/A
Recruiting	Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorde NCT06081348	Holland Bloorview Kids Rehabilitation Hospital	Phase 2
Active Not Recruiting	Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome NCT06315751	Noema Pharma AG	Phase 2
Recruiting	A Multicenter Pediatric Deep Brain Stimulation Registry NCT06585618	Boston Children's Hospital	—
Recruiting	Remote Delivery of a Mindfulness-based Intervention for Tics NCT06408662	Johns Hopkins University	N/A
Recruiting	Epidemiology of Assertiveness and Emotion Management Disorders in People With Tourette's Syndrome NCT06136572	University Hospital, Clermont-Ferrand	N/A
Recruiting	Multimodal Profiling of Response to Pediatric Comprehensive Behavioral Intervention for Tics NCT06194305	University of Minnesota	Phase 2
Recruiting	Washed Microbiota Transplantation for Tourette's Syndrome NCT03764748	The Second Hospital of Nanjing Medical University	Phase 1
Recruiting	Clinical Characteristics and Temporal Properties of Individual Tics in Persistent Tic Disorder NCT06385535	University of Utah	N/A
Recruiting	Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-blind, Randomized, Controlled Stu NCT05705999	West Virginia University	N/A
Recruiting	Internet-based Behavior Therapy for Adults With Tourette Syndrome NCT06271083	Karolinska Institutet	N/A
Active Not Recruiting	A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's D NCT06021522	Emalex Biosciences Inc.	Phase 3
Unknown	Evaluation of an Online Comprehensive Behavioral Intervention for Tics (CBIT) Therapist Training Program NCT05547854	University of Utah	N/A
Withdrawn	D-cycloserine Augmented Treatment for Youth With Tic Disorders NCT04357951	Johns Hopkins University	EARLY_Phase 1
Completed	Tourette Discrimination (TD) Stigma Scale NCT05696769	Wake Forest University Health Sciences	—
Withdrawn	New Stereotactic Frame System for Neurosurgery NCT04283812	Mayo Clinic	N/A
Completed	Theta Burst Stimulation to Improve Inhibitory Motor Physiology in Tourette Syndrome NCT05628805	Children's Hospital Medical Center, Cincinnati	N/A
Completed	Deep Brain Stimulation in Tourette Syndrome NCT06388291	University College, London	N/A
Active Not Recruiting	Tourette Deep Brain Stimulation (DBS) Target Detection & Suppression NCT05371041	University of Florida	N/A
Completed	Investigating Distress Tolerance in Adults With Tourette Syndrome NCT05047705	Johns Hopkins University	N/A
Terminated	Atomoxetine in Patients With Tourette's Syndrome NCT04354103	Poitiers University Hospital	Phase 2
Completed	Investigations of the Pathophysiology of Gilles de la Tourette Syndrome. Part 1: Simultaneous PET and 3T MRI NCT05232955	Max Planck Institute for Human Cognitive and Brain Sciences	—
Completed	Epidiolex in Obsessive Compulsive Disorder and Related Disorders NCT04978428	University of Chicago	Phase 2
Completed	Median Nerve Stimulation for Tourette Syndrome and Chronic Tic Disorder NCT05269953	Nottingham University Hospitals NHS Trust	N/A
Unknown	Evaluate the Efficacy, Safety and Tolerability of TSUPPORT for Adults With Tourette Syndrome NCT05183594	Tasly Pharmaceuticals, Inc.	N/A
Completed	A Study to Explore the Effect of Sepranolone in Tourette Syndrome NCT05434546	Asarina Pharma	Phase 2
Completed	Investigations of the Pathophysiology of Gilles de la Tourette Syndrome. Part 2: 7T MRI NCT05233306	Max Planck Institute for Human Cognitive and Brain Sciences	—
Withdrawn	Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Tourette Syndrome NCT05158439	The Foundation for Orthopaedics and Regenerative Medicine	Phase 1
Completed	Combined CBIT and rTMS to Improve Tourette's Syndrome NCT04795908	University of Florida	N/A
Completed	Open-label MNS for Tourette Syndrome NCT05016765	Washington University School of Medicine	N/A
Recruiting	Longitudinal Impact of Stressors in Adults With Tourette Syndrome NCT04851678	Vanderbilt University Medical Center	—
Enrolling By Invitation	Neural Correlates of Sensory Phenomena in Tourette Syndrome NCT03914664	Vanderbilt University Medical Center	—
Completed	Median Nerve Stimulation Pilot NCT04731714	Washington University School of Medicine	N/A
Unknown	Internet-based Cognitive Behavioral Therapy for Chronic Tic Disorder and Tourette's Disorder: a Feasibility Tr NCT04908969	Karolinska Institutet	N/A
Completed	Influence of Stress and Psychiatric Symptoms on Children With Tourette Syndrome NCT04449003	Vanderbilt University Medical Center	—
Completed	A Handwriting Intervention Program for Children With Tic Disorders NCT04246112	University of Alabama at Birmingham	N/A
Recruiting	Observational Database on Deep Brain Stimulation in Tourette Syndrome NCT04449068	Assistance Publique - Hôpitaux de Paris	—
Completed	Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics NCT04578912	University of Minnesota	N/A
Completed	Extinction Learning in Adults With Tourette Syndrome NCT04498364	Johns Hopkins University	N/A
Completed	The Effect of Medical Cannabis on Tics, Premonitory Urge and Psychiatric Comorbidity in Adults With Tourette S NCT05115318	Tel-Aviv Sourasky Medical Center	—
Completed	Sensory Symptoms in Tourette Syndrome and Obsessive-Compulsive Disorder NCT04335175	Vanderbilt University Medical Center	—
Withdrawn	Multi-site Transcranial Magnetic Stimulation Therapy of the Supplementary Motor Area in Children With Tourette NCT03642951	Children's Mercy Hospital Kansas City	N/A
Completed	Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents NCT04007991	Emalex Biosciences Inc.	Phase 2
Completed	Response Inhibition in Tourette Syndrome NCT03628703	Children's Hospital Medical Center, Cincinnati	N/A
Recruiting	Sensory Symptoms in Tourette Syndrome NCT03851484	Vanderbilt University Medical Center	—
Unknown	Deep Brain Stimulation in Forel's H Field in Tourette's Syndrome NCT04342754	University of Sao Paulo General Hospital	N/A
Unknown	Outcomes Mandate National Integration With Cannabis as Medicine NCT03944447	OMNI Medical Services, LLC	Phase 2
Unknown	Exploration of Glutamatergic System With PET Radiotracer in Gilles de la Tourette Patients: Pilot Study (Gluta NCT03681795	University Hospital, Toulouse	N/A
Completed	Pimavanserin Treatment in TS NCT04794413	Joseph Jankovic	EARLY_Phase 1
Completed	Online Mindfulness-based Tic Reduction (Phase Two) NCT03771235	Bowdoin College	N/A
Terminated	Rollover Study for Continuing NBI-98854 Administration in Pediatric Subjects With Tourette Syndrome NCT03732534	Neurocrine Biosciences	Phase 2
Completed	Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder NCT03625453	Abide Therapeutics	Phase 2
Unknown	A Study to Examine the Efficacy of a Therapeutic THX-110 for Tourette Syndrome NCT03651726	Neurothera Labs Inc.	Phase 2
Completed	An Exploratory Study of Continuous Theta Burst Stimulation (cTBS) Based on fMRI in the Treatment of Tic Disord NCT04128397	Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A
Completed	A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS) NCT03571256	Teva Branded Pharmaceutical Products R&D, Inc.	Phase 3
Terminated	Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Synd NCT03567291	Teva Branded Pharmaceutical Products R&D, Inc.	Phase 3
Completed	Online Remote Behavioural Intervention for Tics (ORBIT) NCT03483493	Nottinghamshire Healthcare NHS Trust	N/A
Completed	Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's Syndrome NCT03487783	Otsuka Beijing Research Institute	Phase 3
Completed	Impulse Control in Gilles de la Tourette Syndrome NCT04197804	I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio	—
Unknown	tDCS in Tourette (TIC-TDCS) NCT03401996	University of Calgary	N/A
Terminated	Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome NCT03530293	Neurocrine Biosciences	Phase 2
Terminated	Gilles de la Tourette Syndrome (TS) and Seasonality NCT04076852	I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio	—
Completed	CANNAbinoids in the Treatment of TICS (CANNA-TICS) NCT03087201	Hannover Medical School	Phase 3
Completed	Online Mindfulness-based Tic Reduction NCT03525626	Bowdoin College	N/A
Completed	Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Sy NCT03444038	Neurocrine Biosciences	Phase 2
Completed	Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Trea NCT03452943	Teva Branded Pharmaceutical Products R&D, Inc.	Phase 2 / Phase 3
Completed	Role of Frontal Cortex in the Pathophysiology of Gilles de la Tourette Syndrome (GTS) NCT03604510	University Hospital, Bordeaux	N/A
Terminated	Safety and Efficacy of Cannabis in Tourette Syndrome NCT03247244	University Health Network, Toronto	Phase 2
Completed	Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome NCT03325010	Neurocrine Biosciences	Phase 2
Unknown	The Role of Probiotics PS128 in Movement Disorders NCT03259971	National Taiwan University Hospital	N/A
Completed	Effects of Ondansetron in Obsessive-compulsive and Tic Disorders NCT03239210	NYU Langone Health	Phase 4
Completed	Behavioral Therapy for Tourette Syndrome NCT03019731	Johns Hopkins University	N/A
Completed	A Study to Evaluate the Effects of ABX-1431 on Patients With Tourette Syndrome NCT03058562	Abide Therapeutics	Phase 1
Completed	Efficacy of a Therapeutic Combination of Dronabinol and PEA for Tourette Syndrome NCT03066193	Yale University	Phase 2
Unknown	The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Tourette Syndrome NCT02253498	Beijing Pins Medical Co., Ltd	EARLY_Phase 1
Completed	Impulsivity in Tourette Syndrome : Behavioral and Neuroimaging Study NCT02960698	Institut National de la Santé Et de la Recherche Médicale, France	N/A
Completed	Trial to Demonstrate the Efficacy and Safety of Internet-delivered Behavioral Treatment for Adults With Tic Di NCT02605902	Hannover Medical School	N/A
Completed	Incorporating teleCBIT Into a Hospital-Based Tic Program NCT04007913	San Jose State University	N/A
Completed	Modified Comprehensive Behavioral Intervention for Tics (M_CBIT) NCT02900144	Massachusetts General Hospital	N/A
Completed	Safety and Tolerability Study of NBI-98854 for the Treatment of Subjects With Tourette Syndrome NCT02879578	Neurocrine Biosciences	Phase 2
Completed	Computerized Working Memory Training in Children With ADHD and Comorbid Tourette Syndrome NCT02732496	Massachusetts General Hospital	N/A
Completed	Evaluation of a Cognitive Psychophysiological Treatment for Tourette Syndrome and Tic Disorders NCT03225430	Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal	N/A
Completed	Apathy in Tourette Syndrome and Changes in Quality of Life NCT02765178	University of Florida	—
Completed	Safety and Efficacy Study of NBI-98854 in Children and Adolescents With Tourette Syndrome NCT02679079	Neurocrine Biosciences	Phase 2
Completed	Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome NCT02581865	Neurocrine Biosciences	Phase 2
Completed	Sensory Processing in Tourette Syndrome NCT02512406	University of Florida	—
Completed	Transcranial Magnetic Stimulation for Children With Tourette's Syndrome NCT02356003	University of Calgary	N/A
Unknown	Group Intervention for Children With Chronic Tics Syndrome or Tourette Syndrome: CBIT vs Psycho-Educational In NCT02407951	Tel-Aviv Sourasky Medical Center	N/A
Withdrawn	A Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of SNC-102 in Subjects With Tourette Syndrome NCT02217007	Synchroneuron Inc.	Phase 2
Unknown	The Effect and Safety of Plum-blossom Needle for Tourette Syndrome NCT02403258	Guang'anmen Hospital of China Academy of Chinese Medical Sciences	N/A
Completed	Behavioral Therapy for Children and Adolescents With Tourette Syndrome NCT03621059	Taipei Medical University	N/A
Completed	Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome NCT02256475	Neurocrine Biosciences	Phase 1
Completed	Brain Stimulation in Movement Disorders NCT02216474	Birmingham and Solihull Mental Health NHS Foundation Trust	N/A
Completed	A Pilot Study Of SD-809 (Deutetrabenazine) In Moderate To Severe Tourette Syndrome (TS) NCT02674321	Auspex Pharmaceuticals, Inc.	Phase 1
Unknown	Parent Behavioral Training for Disruptive Behaviors in Tourette Syndrome NCT02882490	Hospital Clinic of Barcelona	N/A
Terminated	FAAH Inhibitor Trial for Adults With Tourette Syndrome NCT02134080	Yale University	Phase 1
Completed	Thalamic Deep Brain Stimulation for Tourette Syndrome NCT03958617	University of Cologne	Phase 2 / Phase 3
Completed	Activity in Tourette Syndrome NCT02153463	Children's Hospital of Eastern Ontario	N/A
Completed	Tourette Syndrome Deep Brain Stimulation NCT02056873	University of Florida	N/A
Completed	Proof of Concept Study of an Oral Orthotic to Reduce Tic Severity in Chronic Tic Disorder and Tourette Syndrom NCT02067819	Weill Medical College of Cornell University	N/A
Terminated	Thalamic Deep Brain Stimulation for the Treatment of Refractory Tourette Syndrome NCT01817517	Johns Hopkins University	N/A
Unknown	Pilot Study for Use of Dysport in Treatment of Vocal Tics in Patients With Tourette's Syndrome NCT02187679	Detroit Clinical Research Center	N/A
Unknown	The Pathophysiology of Tourette Syndrome: a Multimodal Study NCT02497807	Second Affiliated Hospital, School of Medicine, Zhejiang University	—
Completed	Safety, Tolerability, Pharmacokinetic, and Efficacy Study of AZD5213 in Adolescents With Tourette's Disorder NCT01904773	AstraZeneca	Phase 2
Completed	VoIP Delivered Behavior Therapy for Tourette Syndrome NCT02247206	University of Wisconsin, Milwaukee	Phase 2
Completed	Open-Trial of EPI-743 for Adults With Tourette Syndrome NCT01719523	Yale University	Phase 1
Completed	Neurofeedback for Tourette Syndrome NCT01702077	Yale University	N/A
Completed	Guanfacine in Children With Tic Disorders NCT01547000	Yale University	Phase 4
Completed	Subthalamic Stimulation in Tourette's Syndrome NCT02619084	Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta	Phase 2
Completed	Developing Cognitive Training for Tourette Syndrome NCT01440023	University of Wisconsin, Milwaukee	Phase 1
Completed	A Trial of Bilateral Deep Brain Stimulation to the Globus Pallidus Internum in Tourette Syndrome NCT01647269	University College, London	Phase 2
Completed	Repetitive Transcranial Magnetic Stimulation to Reduce Tics NCT01258790	Children's Hospital Medical Center, Cincinnati	N/A
Completed	Assessment of Children With Tic Onset in the Past 6 Months NCT01177774	Washington University School of Medicine	—
Active Not Recruiting	Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals NCT01075672	Massachusetts General Hospital	N/A
Completed	MRI Study of Tic Remission in Tourette Syndrome NCT01405859	University of Utah	—
Completed	Developing New Treatments for Tourette Syndrome: Therapeutic Trials With Modulators of Glutamatergic Neurotran NCT01018056	Johns Hopkins University	Phase 4
Completed	Brain Stimulation for the Treatment of Tourette Syndrome NCT01329198	University of Florida	N/A
Terminated	Investigation of Neurofeedback With Real-Time fMRI in Healthy Volunteers and Patients With Hyperkinetic Moveme NCT00885040	National Institute of Neurological Disorders and Stroke (NINDS)	—
Completed	Role of the Sensory Experience in Generating Motor Tics in Tourette Syndrome NCT00755339	National Institute of Neurological Disorders and Stroke (NINDS)	—
Terminated	Pilot Study of the Modified Atkins Diet for Tourette Syndrome NCT00952601	Johns Hopkins University	Phase 1
Terminated	Open-label Extension Study of Pramipexole in the Treatment of Children and Adolescents With Tourette Syndrome NCT00681863	Boehringer Ingelheim	Phase 3
Completed	Pramipexole Pilot Phase II Study in Children and Adolescents With Tourette Disorder According to DSM-IV Criter NCT00558467	Boehringer Ingelheim	Phase 2
Completed	Phase III Study of 5LGr to Treat Tic Disorder NCT01501695	Tasly Pharmaceuticals, Inc.	Phase 3
Completed	Transcranial Magnetic Stimulation (TMS) for Individuals With Tourette's Syndrome NCT00529308	Yale University	Phase 2
Completed	Comparison of Keppra and Clonidine in the Treatment of Tics NCT00370838	Harvey S. Singer	Phase 4
Unknown	Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders. NCT00355927	Hadassah Medical Organization	N/A
Completed	Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol) NCT00634556	Washington University School of Medicine	Phase 1
Completed	Effectiveness of Behavior Therapy and Psychosocial Therapy for the Treatment of Tourette Syndrome and Chronic NCT00231985	Massachusetts General Hospital	Phase 2
Completed	Brain Activity Associated With Tics in Patients With Tourette Syndrome NCT00141869	National Institute of Neurological Disorders and Stroke (NINDS)	—
Completed	Thalamic Deep Brain Stimulation for Tourette Syndrome NCT00311909	University Hospitals Cleveland Medical Center	Phase 2
Completed	Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children NCT00218777	Tourette Association of America	Phase 2 / Phase 3
Completed	An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome. NCT00206336	Baylor College of Medicine	Phase 3
Completed	A Randomized, Placebo-controlled, Tourette Syndrome Study. NCT00206323	Baylor College of Medicine	Phase 3
Completed	Timing of Voluntary Movement in Patients With Tourette Syndrome and Chronic Tic Disorder NCT00081419	National Institute of Neurological Disorders and Stroke (NINDS)	—
Completed	Brain Dynamics Involved in Generating Tics and Controlling Voluntary Movement NCT00056420	National Institute of Neurological Disorders and Stroke (NINDS)	—
Completed	Study of GABA-A Receptors in the Generation of Tics in Patients With Tourette's Syndrome NCT00034398	National Institute of Neurological Disorders and Stroke (NINDS)	—
Completed	Study of Tics in Patients With Tourette's Syndrome and Chronic Motor Tic Disorder NCT00033995	National Institute of Neurological Disorders and Stroke (NINDS)	—
Completed	Magnetic Resonance Spectroscopy to Evaluate Tourette s Syndrome NCT00030953	National Institute of Neurological Disorders and Stroke (NINDS)	—
Completed	Anger Control Training for Youth With Tourette Syndrome NCT00486551	Yale University	N/A
Completed	Methylphenidate for Treating Children With ADHD and Tourette Syndrome NCT00441649	Stony Brook University	N/A
Completed	Evaluation and Follow-up of Individuals With Obsessive-Compulsive Disorder and Related Conditions NCT00004550	National Institute of Mental Health (NIMH)	—
Completed	I-123 Brain Studies of Serotonin Metabolism in Psychiatric Patients and Normal Volunteers NCT00001771	National Institute of Mental Health (NIMH)	—
Completed	Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome NCT00004393	National Center for Research Resources (NCRR)	Phase 2
Completed	Randomized Study of Pergolide in Children With Tourette Syndrome NCT00004433	Children's Hospital Medical Center, Cincinnati	N/A
Completed	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention NCT00004376	National Center for Research Resources (NCRR)	Phase 3
Completed	Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in Tourette Syndrome NCT00004652	National Center for Research Resources (NCRR)	Phase 2
Terminated	Central Mechanisms in Speech Motor Control Studied With H215O PET NCT00001308	National Institute on Deafness and Other Communication Disorders (NIDCD)	—
Completed	Developmental Phenomenology of Obsessive Compulsive Disorder and Tourette Syndrome in Children and Adolescents NCT00004324	National Center for Research Resources (NCRR)	—
Completed	Study of the Neurobiology of Tourette Syndrome and Related Disorders NCT00004325	National Center for Research Resources (NCRR)	—
Unknown	National Gilles De La Tourette Study Group NCT00169351	Groupe Hospitalier Pitie-Salpetriere	—